Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
564 Leser
Artikel bewerten:
(2)

Deutsche Digital Assets Lists DDA Crypto Select 10 ETP (SLCT) on Deutsche Börse Xetra

  • DDA Crypto Select 10 ETP (ISIN: DE000A3G3ZD0; WKN: A3G3ZD, Ticker: SLCT) is now listed and starts trading on Deutsche Börse Xetra on June 27, 2023
  • DDA Crypto Select 10 ETP tracks the MarketVector Digital Assets Max 10 VWAP Close Index ("MVDAMV")
  • With the newly launched ETP, investors can gain exposure to a basket of top 10 crypto assets in a cost-effective way
  • The ETP is 100% collateralized by coins held in an institutional-grade custody solution with Aplo SAS

FRANKFURT, Germany, June 27, 2023 (GLOBE NEWSWIRE) -- DDA Crypto Select 10 ETP (ISIN: DE000A3G3ZD0; WKN: A3G3ZD, Ticker: SLCT) is now listed and starts trading on Deutsche Börse's Xetra on June 27, 2023. The exchange traded product (ETP) becomes a cost-effective way for investors to gain exposure to the top 10 largest crypto assets by market capitalization on Xetra with a total expense ratio of 1.69%.

The DDA Crypto Select 10 ETP is 100% physically backed by a basket of cryptocurrencies composing the MarketVector Digital Assets Max 10 VWAP Close Index ("MVDAMV") and is held in an institutional-grade custody solution with with Aplo SAS.

The ETP offers investors the opportunity to achieve portfolio diversification with a single investment, which is a significant advantage for those seeking to balance their portfolio risk or gain exposure to a variety of crypto assets.

"We are excited to announce the listing of DDA Crypto Select 10 ETP, our first multi-asset crypto ETP, which represents a major step forward in our product offerings and unlocks new opportunities for our valued investors," said Dominik Poiger, CFA, Chief Product Officer of DDA. "The DDA Crypto Select 10 ETP was designed with institutional and individual investor interests in mind and allows them to gain exposure to a variety of crypto assets."

"We are proud to partner with Deutsche Digital Assets to support the launch of their innovative Crypto Select 10 ETP," said Steven Schoenfeld, CEO of MarketVector. "We are confident that MarketVector's experience with both multi-asset crypto benchmarks and optimizing investability and liquidity will benefit investors of this new ETP."

"We're thrilled to see our MarketVector Digital Assets Max 10 VWAP Close Index underpin the new DDA Crypto Select 10 ETP," Martin Leinweber, CFA, Digital Asset Product Strategist of MarketVector. "This index provides a balanced and diversified selection of the top 10 cryptocurrencies, providing a robust basis for this innovative ETP. It marks another step in our commitment to delivering effective and dynamic indexes in the evolving digital asset market. We look forward to continued collaboration with DDA and to further advancing the digital asset ecosystem together."

The new listing complements DDA's offering of crypto exchange traded products including DDA Physical Bitcoin ETP(IETH, ISIN: DE000A3GTML1) on multiple European exchanges. The company also has its DDA Physical ApeCoin ETP (IAPE, ISIN: DE000A3GYNY2) listed on Börse Stuttgart.

For more information on the DDA Crypto Select 10 ETP, please visit the DDA website https://deutschedigitalassets.com/select-10/or contact the team directly under contact@deutschedigitalassets.com.

Product nameDDA Crypto Select 10 ETP
Ticker Xetra / BloombergSLCT / SLCT GY
ISIN / WKNDE000A3G3ZD0 / A3G3ZD
TER1.69%
Base CurrencyUSD
Trading CurrencyEUR
UnderlyingMarketVector Digital Assets Max 10 VWAP Close Index ("MVDAMV")
Product StructurePhysically replicating
Rebalancing FrequencyQuarterly
Index ProviderMarketVector
DomicileLiechtenstein
IssuerDDA ETP AG
Security TrusteeBankhaus von der Heydt GmbH & Co. KG
Custodian(s)Aplo SAS
Authorized Participant(s)Flow Traders B.V.
Jane Street Financial Ltd.
DRW Europe B.V.
Bluefin Europe LLP
Launch date

May 22, 2023
Listing dateJun 27, 2023

About Deutsche Digital Assets -www.deutschedigitalassets.com

Established in 2017, Deutsche Digital Assets GmbH (DDA) is a German crypto and digital asset manager that serves as a trusted gateway for investors seeking exposure to crypto assets. DDA, through various subsidiaries, offers a menu of crypto investment products and solutions, ranging from passive to actively managed, as well as financial product white-labeling services for asset managers. By leveraging traditional financial products, DDA provides investors with familiar access to a range of crypto asset ETPs, professional investment funds, and hedgefunds strategies, making crypto and digital asset acquisition as easy as buying a stock. For more information, please visit https://deutschedigitalassets.com/

Press contact:

Syuzanna Avanesyan
press@deutschedigitalassets.com
www.deutschedigitalassets.com

About MarketVector Indexes - www.marketvector.com

MarketVector IndexesTM ("MarketVector") is a regulated Benchmark Administrator in Europe, incorporated in Germany and registered with the Federal Financial Supervisory Authority (BaFin). MarketVector maintains indexes under the MarketVectorTM, MVIS®, and BlueStar® names. With a mission to accelerate index innovation globally, MarketVector is best known for its broad suite of Thematic indexes, long-running expertise in Hard Asset-linked Equity indexes, and its pioneering Digital Asset index family. MarketVector is proud to be in partnership with more than 25 Exchange-Traded Product (ETP) issuers and index fund managers in markets throughout the world, with approximately USD27 billion in assets under management.

Media Contacts:

Eunjeong Kang, MarketVector
+49

Sam Marinelli, Gregory FCA on behalf of MarketVector
610-246-9928
sam@gregoryfca.com

Important Notices:
This article represents solely a non-binding preliminary information which serves exclusively advertising purposes. It is not a prospectus in the sense of the Regulation (EU) 2017/1129(Prospectus Regulation) and the German Securities Prospectus Act (Wertpapierprospektgesetz - WpPG). It does not constitute an offer of securities for sale in the United States and the securities referred to in this notice may not be offered or sold in the United States absent registration or an exemption from registration.

Risk Considerations:
The price of an investment in a DDA ETP may go up or down and the investor may not get back the amount invested. The price performance of cryptocurrencies is highly volatile and unpredictable. Past performance is hence no guarantee of future performance. You agree to do your own research and due diligence before making any investment decision with respect to securities or investment opportunities discussed herein. The approval of the prospectus should not be construed as an endorsement of the securities offered or admitted to trading on a Regulated Market. These are not extensive risk considerations. Prospective investors should read the prospectus before making any investment decision in order to fully understand the potential risks and rewards of deciding to invest in the securities.

The prospectus is available at https://deutschedigitalassets.com/


© 2023 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.